Challenges in Drug Development for Transplantation

The chapter delves into the hurdles faced in drug development for transplantation, advocating for clearer pathways for companies and investors. It addresses issues with trials, the necessity of improved endpoints, potential legislative support for regulatory authorities, resource allocation impacting patient health and innovation, as well as the broader impact on patient quality of life.